Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

Marnix Lameijer,Tina Binderup,Mandy M. T. van Leent,Max L. Senders,Francois Fay,Joost Malkus,Brenda L. Sanchez-Gaytan,Abraham J. P. Teunissen,Nicolas Karakatsanis,Philip Robson,Xianxiao Zhou,Yuxiang Ye,Gregory Wojtkiewicz,Jun Tang,Tom T. P. Seijkens,Jeffrey Kroon,Erik S. G. Stroes,Andreas Kjaer,Jordi Ochando,Thomas Reiner,Carlos Pérez-Medina,Claudia Calcagno,Edward A. Fisher,Bin Zhang,Ryan E. Temel,Filip K. Swirski,Matthias Nahrendorf,Zahi A. Fayad,Esther Lutgens,Willem J. M. Mulder,Raphaël Duivenvoorden
IF: 28.1
2018-01-01
Nature Biomedical Engineering
Abstract:In the version of this Article originally published, the surname of the author Edward A. Fisher was spelt incorrectly as ‘Fischer’. This has now been corrected.
What problem does this paper attempt to address?